182 related articles for article (PubMed ID: 19123201)
1. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
[TBL] [Abstract][Full Text] [Related]
4. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
[TBL] [Abstract][Full Text] [Related]
5. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
[TBL] [Abstract][Full Text] [Related]
6. Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
Cody NA; Ouellet V; Manderson EN; Quinn MC; Filali-Mouhim A; Tellis P; Zietarska M; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
Oncogene; 2007 Jan; 26(4):618-32. PubMed ID: 16909122
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
[TBL] [Abstract][Full Text] [Related]
8. Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer.
Rimessi P; Gualandi F; Morelli C; Trabanelli C; Wu Q; Possati L; Montesi M; Barrett JC; Barbanti-Brodano G
Oncogene; 1994 Dec; 9(12):3467-74. PubMed ID: 7970706
[TBL] [Abstract][Full Text] [Related]
9. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.
Warrenfeltz S; Pavlik S; Datta S; Kraemer ET; Benigno B; McDonald JF
Mol Cancer; 2004 Oct; 3():27. PubMed ID: 15471544
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
[TBL] [Abstract][Full Text] [Related]
12. Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.
Stronach EA; Sellar GC; Blenkiron C; Rabiasz GJ; Taylor KJ; Miller EP; Massie CE; Al-Nafussi A; Smyth JF; Porteous DJ; Gabra H
Cancer Res; 2003 Dec; 63(24):8648-55. PubMed ID: 14695176
[TBL] [Abstract][Full Text] [Related]
13. Screening for genes associated with ovarian cancer prognosis.
Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
[TBL] [Abstract][Full Text] [Related]
14. Screening of the metastasis-associated genes by gene chip in high metastatic human ovarian cancer cell lines.
Xu S; Mou H; Gu L; Su D; Zhu C; Liu X
J Genet Genomics; 2007 Jul; 34(7):581-90. PubMed ID: 17643943
[TBL] [Abstract][Full Text] [Related]
15. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
16. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.
Urzúa U; Roby KF; Gangi LM; Cherry JM; Powell JI; Munroe DJ
J Cell Physiol; 2006 Mar; 206(3):594-602. PubMed ID: 16245302
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
20. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).
Zietarska M; Maugard CM; Filali-Mouhim A; Alam-Fahmy M; Tonin PN; Provencher DM; Mes-Masson AM
Mol Carcinog; 2007 Oct; 46(10):872-85. PubMed ID: 17455221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
